You are here: Industry Insights > AI

News List

Colorcon Ventures Invests in Bio-Simulation Startup VeriSIM Life contractpharma
January 18, 2022
VeriSIM’s platform accelerates drug development and reduces animal testing.
Japan's Top Home Security Company SECOM Invests in AI Startup LiveSmart prnewswire
August 12, 2021
LiveSmart is helping develop self-monitoring solutions for seniors and cloud-based security solutions for SECOM, the largest home security company in the world by revenue.
Deep Genomics raises $180m to advance drugs for genetic diseases pharmaceutical-technology
July 30, 2021
Deep Genomics has secured $180m in Series C funding round to advance its artificial intelligence (AI)-discovered drug programmes for genetic diseases into the clinic.
Texas Cardiac Arrhythmia Institute leader participates in clinical trial for world's first artificial intelligence technology for complex cardiac arrhythmia procedures prnasia
July 23, 2021
The leader of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently led a clinical study to evaluate the world's first data-driven artificial intelligence (AI) platform for cardiac electrophysiology (EP) procedures.
Digital New Deal Startups Gain Global Attention prnasia
July 20, 2021
The Born2Global Centre released an article that highlights the Ministry of Science and ICT (MSIT)'s effort to support technology startups, included in the Korean Digital New Deal.
AI and big data will continue to disrupt pharma sector, says survey europeanpharmaceuticalreview
July 20, 2021
A GlobalData report has revealed the extent to which companies will be using AI and big data in drug discovery and development processes.
AI, big data will continue to disrupt pharma sector, say healthcare industry professionals in GlobalData survey expresspharma
July 19, 2021
The COVID-19 pandemic has given businesses an unprecedented opportunity to implement technology-fueled changes to the way they operate.
Artificial intelligence could be new blueprint for precision drug discovery worldpharmanews
July 13, 2021
Writing in the July 12, 2021 online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is ...
I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge mRNA and AI Technology Platforms prnasia
July 12, 2021
I-Mab announced the signing of two new collaborations with emerging biotech companies in China to strengthen its next-generation innovation pipeline.
Kuano raises £1m to further develop AI drug discovery platform pharmatimes
July 09, 2021
London-headquartered artificial intelligence company Kuano has raised £1m in seed funding to accelerate the development of its platform, focused on transforming the discovery of therapeutics targeting enzyme inhibition.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page